Neogenomics (NEO) Restructuring Costs (2022 - 2024)

Neogenomics (NEO) has reported Restructuring Costs for 3 consecutive years, with $2.4 million the latest figure, recorded in Q1 2024.

• Restructuring Costs for Q1 2024 came in at $2.4 million, down 48.8% year-over-year; the trailing twelve-month figure through Mar 2024 was $8.8 million (down 4.33% YoY), and the FY2024 annual result was $6.7 million, down 39.95% from the prior year.
• Restructuring Costs was $2.4 million for Q1 2024 at Neogenomics, up from $1.2 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $4.7 million in Q1 2023 and troughed at $1.2 million in Q4 2023.
• Average Restructuring Costs over 3 years is $3.0 million, with a median of $2.7 million recorded in 2023.
• Year-over-year, Restructuring Costs tumbled 73.32% in 2023 and plunged 48.8% in 2024.
• Over 3 years, Restructuring Costs stood at $4.5 million in 2022, then sank by 73.32% to $1.2 million in 2023, then soared by 99.0% to $2.4 million in 2024.
• Per Business Quant data, the three most recent Restructuring Costs figures were $2.4 million in Q1 2024, $1.2 million in Q4 2023, and $2.1 million in Q3 2023.